BDBM50110069 3-Chloro-4-hydroxy-N-{2-[4-(4-isopropyl-benzyloxy)-3,5-dimethoxy-phenyl]-ethyl}-benzamide::CHEMBL161494
SMILES: COc1cc(CCNC(=O)c2ccc(O)c(Cl)c2)cc(OC)c1OCc1ccc(cc1)C(C)C
InChI Key: InChIKey=CYHKZTFZZFYCMM-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glucagon receptor (Homo sapiens (Human)) | BDBM50110069 (3-Chloro-4-hydroxy-N-{2-[4-(4-isopropyl-benzyloxy)...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | 1.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development Curated by ChEMBL | Assay Description In vitro inhibitory activity against human glucagon receptor using [127I]-labeled glucagon | Bioorg Med Chem Lett 12: 663-6 (2002) BindingDB Entry DOI: 10.7270/Q2J67G77 | |||||||||||
More data for this Ligand-Target Pair |